How to Process Medical Insurance Claims and How Long Does It Take?

Medical Insurance Claims Process

A medical insurance claim is a document submitted by a doctor after having procedures and observations done providing a list of medical services to be paid. As usual, a client isn’t involved in the medical claims process – a doctor sends a bill for medical services to a client’s insurance company which will pay for the provided services. Then it’s checked by a claims processor for adequacy according to the client’s health insurance plan and accuracy.

If everything is alright, a doctor receives payment from the insurance company. A patient can file the claim by themselves, or it can be automatically submitted after the provided services, and strictly following the Health Insurance Portability and Accountability Act requirements which preserve data security.

However, there can be some threats with health insurance claims, so the insurer can deny it considering the following points:

  • Incorrect diagnosis, procedures code, errors in digits, names.
  • Absence of preauthorization for a procedure
  • Incorrectly defined medical necessity.
  • Missing the deadlines.

Nevertheless, some insurers can offer patients particular software or online tools which eliminate the possibility of medical insurance claim denial. These programs facilitate patients’ satisfaction and help them to avoid controversies. For example, medical billing software assists patients to define the exact procedure name, code, and extra conditions for signing up.

These tools can also notify you about claim submission deadlines, so you’ll send it on time to the insurance company. Medical billing software is useful when you need to know whether your practice doctor belongs to the network covered by the insurer. Learn more how to automate medical claims to customize services and provide EMR software solutions in this article.

How Long Do Medical Claims Take to Process?

When answering the question about how long do medical claims take to process, it depends on the claim type – whether it’s cashless or a reimbursement one. The first type means that a patient has to provide a health insurance card in the hospital, so the majority of the insurance companies approve such treatment within four hours after you admit to the hospital. Although, before the visit, a patient should inform a third-party administrator in advance (three days priorly) to provide a personal membership number.

In case of reimbursement, you need to contact your insurance company, prepare all the necessary hospital bills, fill out the form to reimburse, and submit it to get approval. Generally, the processing time is around 20 days from the day of receiving the documents.

Speaking about a medical negligence claims process, it means that a patient suffers from the outcomes of a doctor’s mistake, and this document must be presented properly to be assessed smoothly without delay. There’s the time limit for this claim is three years from the day the negligence occurred, because a patient should have some time to notice symptoms or illness.

It’s important to consider the medical claims audit process that involves a systematic and detailed analysis of the filed records to assess a patient’s needs and complaints. Meanwhile, to eliminate potential discrepancies with the manual medical insurance claims process, a patient can use electronic medical and healthcare records where authorized medical services providers have access to diverse medical data of their patients.

Such tools, like Romexsoft, aim to provide a client-centered model of relationships between patients, hospitals, and health insurance companies, along with figuring out how to process medical insurance claims easily. Another option that can automate medical insurance claim processes is RPA, i.e. robotic process automation based on the AI principles. So, automation ensures executing reliable and efficient decisions, optimizing workflow, performing all tasks without errors, and guaranteeing smooth health insurance claims processing.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”